Result
€3.1m €3.1m
Back in profit in 2025, after a loss of €2.6m in 2024.
ScarPro
Lifetime
19 annual accounts with figures on one time axis, 31 filings since 1994peak €4.7m (2025)
€4.7m▲ 131%
lowest -€2.6m (2024)
€3.1m▲ €5.7m
peak €1.8m (2025)
€1.8m▲ €3.1m
€5.2m▼ 8.6%
peak 30.4 FTE (2025)
30.4 FTE▲ 34.5%
Board11 names since 2016
2 directors and 1 other
Owners2 names in the annual accounts
consolidates
Documentsfilings and deeds
19-10-202680 days late
2025abbreviated format
Gross margin from €2.0m to €4.7mBack to profit: €3.1mStaff from 22.6 FTE to 30.4 FTE1 director appointed, 2 resignations 07-07Equity from -€1.4m to €1.8mCash from €2,026 to €304,475
Key points
from the 2025 annual accountsDebts
€5.2m 75% of the balance sheet
Financial debts 13%Suppliers 10%Taxes and wages 6%Other 71%
Of this, €4.6m falls due within a year.
Staff
36 employees on 31-12-2025
In 2025, 52 people joined and 45 left.
Liquidity
1.28 was 0.73 in 2024
Short-term debts fell from €5.0m to €4.6m.
Filings
31 annual accounts 80 days
Latest accounts filed late: after the legal deadline.
Subsidiaries
-€2.8m
Subsidiary with negative equity. · loss of €1.8m in 2024.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,611 companies had the same profile as ScarPro has now. Each dot stands for 7 companies, two years later.
97.3%
were still trading
2.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,611 companies, not a prediction for ScarPro. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Managing director
Managing director
Director, since 01-03-2025
- 100%equity -€2.4m (2025) · 2025 annual accounts of
- consolidatesannual accounts 2025
Recent changes
Resignation: (day-to-day manager)
Gazette deed
Purpose change · Amendment of the articles
“De productie,verkoop en handel van medische en cosmetische producten en alle aanverwante producten,dit alles…” (deed in Dutch) · General meeting of 23-03-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0451049505
1 director appointed, 2 resignations
Resignations: (director) and (director) · Appointment: (director) · Permanent representative: · General meeting of 04-03-2025 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ScarPro Aalter | €7.0m | €4.7m | 25.1% | 30.4 |
| Revvity Lier | €6.2m | €5.4m | 55.9% | 28.4 |
| DIAGAM Ath | €7.3m | €4.0m | 55.2% | 23.9 |
| CORIS BIOCONCEPT Gembloux | €6.1m | €3.1m | 82.1% | 31.2 |
| INTERSCIENCE BELGIUM Ottignies-Louvain-la-Neuve | €5.7m | €3.7m | 27.1% | 23.3 |
| MEDIPOST Liège | €6.1m | €3.5m | 59.7% | 36.8 |
| EKI'P DENTAL Wavre | €5.8m | €3.6m | 49.9% | 19.9 |
These companies have the same main activity as ScarPro: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €5.7m and €7.3m, founded between 1986 and 1997.
Official details
Source: KBO- Status
- Active since 30-09-1993Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Establishment unit
- 2.286.823.9939880 Aalter, since 11-03-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 11-11-2025
Annual accounts 2025
- ≈ €20.0mestimated
- €7.0m▲ 50.8%
- Employeeson 31-12-2025
- 36▲ 24.1%
- Filing
- Filed on 19-10-2026
Insights on ScarPro
ScarPro files the abbreviated format. That format states no turnover. The gross margin rose from €39,988 in 2006 to €4.7m in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ScarPro
- What is the company number of ScarPro?
- The company number of ScarPro is 0451.049.505. The VAT number is the same number with BE in front: BE 0451.049.505.
- Where is ScarPro based?
- The registered office is at Lobulckstraat 3, 9880 Aalter.Company details
- What does ScarPro do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of ScarPro?
- ScarPro is a public limited company (NV).
- When was ScarPro founded?
- ScarPro was founded on 30-09-1993.
- Is ScarPro still active?
- Yes, ScarPro is an active enterprise in the KBO register.
- How many employees does ScarPro have?
- ScarPro had an average of 30.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of ScarPro?
- The turnover in financial year 2025 is ≈ €20.0m. This figure is estimated from the gross margin of €4.7m and 98 comparable companies (NACE 46). It probably lies between €12.0m and €33.0m.
- Is ScarPro profitable?
- In financial year 2025, ScarPro made a profit of €3.1m.
- Where can I find the annual accounts of ScarPro?
- ScarPro filed 31 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ScarPro due?
- ScarPro must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.